NDC 68180-797

Banzel

Rufinamide Oral Suspension

Banzel is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is Rufinamide.

• Product ID: 68180-797_c0d2c9e4-ab01-4809-9f1a-9ad4263d0785
• NDC: 68180-797
• Product Type: Human Prescription Drug
• Proprietary Name: Banzel
• Generic Name: Rufinamide Oral Suspension
• Dosage Form: Suspension
• Route of Administration: ORAL
• Marketing Start Date: 2022-04-01
• Marketing Category: ANDA /
• Application Number: ANDA213457
• Labeler Name: Lupin Pharmaceuticals, Inc.
• Substance Name: RUFINAMIDE
• Active Ingredient Strength: 40 mg/mL
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 68180-797-01

1 BOTTLE in 1 CARTON (68180-797-01) > 460 mL in 1 BOTTLE

• Marketing Start Date: 2022-04-01
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Banzel" or generic name "Rufinamide Oral Suspension"

NDC	Brand Name	Generic Name
62856-582	Banzel	rufinamide
62856-583	Banzel	rufinamide
62856-584	Banzel	rufinamide
68180-797	Banzel	Rufinamide Oral Suspension